Back

Adherence to free and single-pill combination of rosuvastatin/ezetimibe: findings from a real-world analysis in italy

13 April 2023 (17:08 - 17:20)
Organised by:
Congress Presentation Part of: Primary Care and Risk Factor Management 2 Drug therapy EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Doctor Leopoldo Perez De Isla

San Carlos Clinical University Hospital, Madrid (Spain)

3 More presentations in this session

Presentation thumbnail
A real-world analysis of adherence and biochemical outcome of patients on rosuvastatin/ezetimibe free vs single-pill combination in italy
Professor L. Perez De Isla (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Relationship of hyperglycaemic and glycaemic fluctuations to major adverse cardiovascular events in type 2 Diabetes Mellitus
Doctor B. Borg (Msida, MT)
Abstract Slides Video
Presentation thumbnail
Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in Spain
Professor P. Valdivielso (Malaga, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Primary Care and Risk Factor Management 2
Video

The Event

Event poster

ESC Preventive Cardiology 2023

13 April 2023 17:08 CET
You may be interested in
thumbnail
Congress Presentation
Adherence to anti-hypertensive therapy with perindopril-based single-pill versus free-pill combinations: a 10-year real-world analysis in Italy
1 September 2024
thumbnail
Congress Presentation
From statins to earlier combination use.
28 August 2022
thumbnail
Congress Presentation
Trajectories of adherence to secondary prevention pharmacotherapy after coronary angiography: a retrospective population-based study
1 September 2025
thumbnail
Congress Presentation
Efficacy and safty of a quadruple combination of amlodipine, losartan, rosuvastatin, and ezetimibe in ASCVD patients with poor medication adherence (AMOREMIO study)
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources